A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease
Clinical trial NCT05331300 · COMPLETED
Trial details
- NCT number
- NCT05331300
- Sponsor
- Lassen Therapeutics 1 PTY LTD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-06
- Primary completion
- 2024-11-27
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.